Table 6. Mean (SE) of dependent variables of the WLT and main effects of Treatment Condition and Task Variable* (Trial); ns = not significant, na = not applicable.
| Treatment Condition (Mean ± SE) | GLM | |||||||
| Treatment Condition | Task variable* | |||||||
| Tests/DV | MDMA | Pindolol + MDMA | Oxytocin | Placebo | F | p | F | p |
| WLT-30 IR/DR | Trial | |||||||
| IRT1 | 8.45 (.74) | 8.20 (.53) | 10.20 (.55) | 9.70 (.58) | 4.35 | .008 | 77.25 | <.001 |
| IRT2 | 12.40 (.96) | 11.60 (.67) | 13.85 (.73) | 12.80 (.78) | ||||
| IRT3 | 13.40 (1.17)a | 13.30 (.96) | 16.05 (1.05) | 16.40 (.93) | ||||
| IRTOT | 34.25 (2.71) | 33.10 (2.00) | 40.10 (2.05) | 38.90 (2.04) | 4.35 | .008 | na | na |
| DR | 9.00 (1.05)a | 8.00 (.85)a | 11.15 (1.14) | 12.15 (1.24) | 6.45 | .001 | na | na |
| WLT-30 Recognition | ||||||||
| Total correct (#) | 12.21 (.50) | 12.28 (.42) | 12.68 (.42) | 12.32 (.59) | .34 | ns | na | na |
| RT correct (msec) | 753.15 (37.36) | 743.52 (31.04) | 762.62 (26.63) | 762.71 (27.67) | .16 | ns | na | na |